rate and tidal volume. The descending limbic pathways were, apparently, not interrupted and emotional stimuli led to modulation of automatic respiration. Automatic respiratory control was, in turn, disrupted by the bilateral pontine lesions and this led to the development of apneustic breathing. The most striking feature of the apneustic pattern was that the inspiratory spasms could only be precipitated by emotional outburst. This finding would support the view that the descending limbic pathway directly influences automatic respiratory control. It also demonstrates that emotional input may precipitate apneustic respiration in the presence of disrupted automatic control due to pontine disease. 
Twenty-five patients (40%) were drivers; mean age 62 years. All experienced syncope. Only 12 drivers had experienced a prodrome prior to syncope; in five, symptoms occurred during head-turning or whilst sitting. In two Group 1 = Motor cyclists and car and light vehicle group drivers Group 2 = Goods Vehicle Drivers, driving vehicles in excess of 3.5 metric tons laden weight, bus drivers and coach drivers. Group 2 standards are also generally applied to emergency police, firemen and ambulance drivers as well as taxi drivers patients, symptoms occurred when driving and one was involved in a fatal motor accident. Most (84%) drivers considered themselves safe to drive and 88% reported that driving was important to them.
The attributable diagnoses in drivers were carotid sinus syndrome in 10 patients (cardioinhibitory in seven and mixed cardioinhibitory or vasodepressor in three), vasovagal syncope (seven patients), atrioventricular block, ventricular tachycardia, orthostatic hypotension, and epilepsy (one each), while in four patients the syncope was unexplained.
Comment
Although 40% of patients attending a syncope clinic were drivers, only 13% had been previously asked about driving and 12% of drivers had experienced symptoms whilst driving. This represents an important oversight on the part of referring doctors.
Attending physicians are often unclear about their responsibilities in reporting such attacks, and about the advice they should give to patients on when to report symptoms and when to drive (table).1 Doctors in the UK should advise patients with syncope to inform the DVLA and should document such discussions. Direct contact with the DVLA is only allowed if there is evidence of continued driving which constitutes a hazard to others. This contrasts with the position in the USA and certain provinces in Canada where the doctor is bound by law to report patients to the licensing authorities. Compliance of patients with reporting requirements to the licensing authorities is also a problem. There is evidence that a significant proportion of patients with epilepsy have driven illegally and have failed to inform the licensing agency.5 Certain insurance companies will abrogate responsibility for damages in accidents involving individuals who fail to report their medical condition. This information should be given to patients when advising about driving.
Advice is not always negative. A diagnosis can be made in many patients with syncope and, after appropriate intervention, patients may resume driving. For syncope which remains unexplained, at least one year off driving with freedom from attacks (for a single episode) or five years off driving with freedom from attacks (for recurrent episodes), is recommended. 4 Thus, general practitioners and hospital doctors should routinely ask patients with syncope about driving status and provide advice appropriate to the current guidelines.
